𝔖 Bobbio Scriptorium
✦   LIBER   ✦

MicroRNA-100 Expression is Independently Related to Biochemical Recurrence of Prostate Cancer

✍ Scribed by Leite, Katia R.M.; Tomiyama, Alberto; Reis, Sabrina T.; Sousa-Canavez, Juliana M.; Sañudo, Adriana; Dall'Oglio, Marcos F.; Camara-Lopes, Luiz H.; Srougi, Miguel

Book ID
122542389
Publisher
Lippincott Williams and Wilkins
Year
2011
Tongue
English
Weight
319 KB
Volume
185
Category
Article
ISSN
0022-5347

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Recurrence-free survival in prostate can
Recurrence-free survival in prostate cancer is related to increased stromal TRAIL expression
✍ Mariam Anees; Peter Horak; Ahmed El-Gazzar; Martin Susani; Georg Heinze; Paul Pe 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 706 KB

## Abstract ## BACKGROUND: TRAIL (tumor necrosis factor related apoptosis‐inducing ligand) is involved in tumor immune surveillance and, thus, may be a potential cancer therapy. TRAIL expression in the tumor microenvironment has been shown to impact cancer survival in multiple tumor types, includi

Cyclooxygenase-2 (cox-2) expression is a
Cyclooxygenase-2 (cox-2) expression is an independent predictor of prostate cancer recurrence
✍ Brian L. Cohen; Pablo Gomez; Yohei Omori; Robert C. Duncan; Francisco Civantos; 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 196 KB 👁 1 views

## Abstract Lack of reliable prognostic markers hinders accurate prediction of disease progression in prostate cancer. The inducible proinflammatory enzyme cyclooxygenase‐2 (COX‐2) is implicated in prostate carcinogenesis, but its role in cancer progression is less clear. We examined whether COX‐2

Expression of microRNA-221 is progressiv
Expression of microRNA-221 is progressively reduced in aggressive prostate cancer and metastasis and predicts clinical recurrence
✍ Martin Spahn; Susanne Kneitz; Claus-Jürgen Scholz; Nico Stenger; Thomas Rüdiger; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 French ⚖ 435 KB

## Abstract Emerging evidence shows that microRNAs (miR) are involved in the pathogenesis of a variety of cancers, including prostate carcinoma (PCa). Little information is available regarding miR expression levels in lymph node metastasis of prostate cancer or the potential of miRs as prognostic m